Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa

ABSTRACT—: We evaluated whether droxidopa, a prodrug converted to norepinephrine, is beneficial in the treatment of symptomatic neurogenic orthostatic hypotension, which results from failure to generate an appropriate norepinephrine response to postural challenge. Patients with symptomatic neurogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Biaggioni, Italo, Freeman, Roy, Mathias, Christopher J., Low, Phillip, Hewitt, L. Arthur, Kaufmann, Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354798/
https://www.ncbi.nlm.nih.gov/pubmed/25350981
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354798/
https://www.ncbi.nlm.nih.gov/pubmed/25350981
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04035

Ejemplares similares